CCI
Columbus Circle Investors Portfolio holdings
AUM
$2.28B
1-Year Return
135.58%
This Quarter Return
+12.7%
1 Year Return
+135.58%
3 Year Return
+366.07%
5 Year Return
+793.68%
10 Year Return
–
AUM
$5.27B
AUM Growth
-$550M
(-9.5%)
Cap. Flow
-$1.19B
Cap. Flow
% of AUM
-22.58%
Top 10 Holdings %
Top 10 Hldgs %
21.09%
Holding
301
New
35
Increased
57
Reduced
81
Closed
115
Top Buys
| 1 |
XPO
XPO
|
+$34.1M |
| 2 |
Urban Outfitters
URBN
|
+$30.7M |
| 3 |
Walmart
WMT
|
+$29.3M |
| 4 |
Air Products & Chemicals
APD
|
+$29M |
| 5 |
Stanley Black & Decker
SWK
|
+$28.8M |
Top Sells
| 1 |
Intuitive Surgical
ISRG
|
+$234M |
| 2 |
CELG
Celgene Corp
CELG
|
+$82.3M |
| 3 |
Booking.com
BKNG
|
+$66.1M |
| 4 |
Albemarle
ALB
|
+$55.9M |
| 5 |
Micron Technology
MU
|
+$51.4M |
Sector Composition
| 1 | Technology | 24.27% |
| 2 | Consumer Discretionary | 16.07% |
| 3 | Industrials | 13.73% |
| 4 | Financials | 12.44% |
| 5 | Healthcare | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
NVIDIA
NVDA
$4.16T
| – | – |
-262,280
| Closed | -$1.17M |
|
227
Novartis
NVS
$248B
| – | – |
-26,309
| Closed | -$2.02M |
|
228
Newell Brands
NWL
$2.65B
| – | – |
-518,138
| Closed | -$22.1M |
|
229
Ocular Therapeutix
OCUL
$2.22B
| – | – |
-1,072,395
| Closed | -$6.63M |
|
230
Oracle
ORCL
$678B
| – | – |
-574,000
| Closed | -$27.8M |
|
231
OraSure Technologies
OSUR
$238M
| – | – |
-527,511
| Closed | -$11.9M |
|
232
Palo Alto Networks
PANW
$132B
| – | – |
-139,134
| Closed | -$3.34M |
|
233
Dave & Buster's
PLAY
$771M
| – | – |
-304,446
| Closed | -$16M |
|
234
Pure Storage
PSTG
$25.9B
| – | – |
-112,838
| Closed | -$1.8M |
|
235
PTC Therapeutics
PTCT
$4.52B
| – | – |
0
| – | – |
|
236
QuidelOrtho
QDEL
$1.93B
| – | – |
-125,491
| Closed | -$5.5M |
|
237
Restaurant Brands International
QSR
$20.3B
| – | – |
-215,528
| Closed | -$13.8M |
|
238
Q2 Holdings
QTWO
$5.25B
| – | – |
-155,778
| Closed | -$6.49M |
|
239
Rocket Pharmaceuticals
RCKT
$346M
| – | – |
-3,750
| Closed | -$27K |
|
240
ResMed
RMD
$40.9B
| – | – |
0
| – | – |
|
241
Revvity
RVTY
$10B
| – | – |
0
| – | – |
|
242
Charles Schwab
SCHW
$170B
| – | – |
-1,129,264
| Closed | -$49.4M |
|
243
Steven Madden
SHOO
$2.22B
| – | – |
-177,158
| Closed | -$5.11M |
|
244
Syndax Pharmaceuticals
SNDX
$1.37B
| – | – |
-42,514
| Closed | -$497K |
|
245
Sarepta Therapeutics
SRPT
$1.85B
| – | – |
-121,758
| Closed | -$5.46M |
|
246
Stratasys
SSYS
$861M
| – | – |
-369,649
| Closed | -$8.55M |
|
247
Supernus Pharmaceuticals
SUPN
$2.58B
| – | – |
-12,035
| Closed | -$481K |
|
248
Tenet Healthcare
THC
$17B
| – | – |
-157,591
| Closed | -$2.59M |
|
249
TJX Companies
TJX
$156B
| – | – |
-561,318
| Closed | -$20.7M |
|
250
Tapestry
TPR
$21.9B
| – | – |
-723,752
| Closed | -$29.2M |
|